HUTCHMED Receives Breakthrough Therapy Designation in China for Amdizalisib (HMPL-689) for ...

HONG KONG and SHANGHAI, China and FLORHAM PARK, N,J., Sept. 13, 2021 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (" HUTCHMED ") (Nasdaq/AIM: HCM; HKEX: 13) today announces that th…